0001493152-23-000191.txt : 20230103 0001493152-23-000191.hdr.sgml : 20230103 20230103215317 ACCESSION NUMBER: 0001493152-23-000191 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230102 FILED AS OF DATE: 20230103 DATE AS OF CHANGE: 20230103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BOLL ANDREW R. CENTRAL INDEX KEY: 0001542150 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35814 FILM NUMBER: 23504236 MAIL ADDRESS: STREET 1: 437 S HWY 101 STREET 2: STE 209 CITY: SOLANA BEACH STATE: CA ZIP: 92075 FORMER NAME: FORMER CONFORMED NAME: Boll Andrew DATE OF NAME CHANGE: 20120210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HARROW HEALTH, INC. CENTRAL INDEX KEY: 0001360214 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 450567010 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 102 WOODMONT BLVD STREET 2: SUITE 610 CITY: NASHVILLE STATE: TN ZIP: 37215 BUSINESS PHONE: 615.733.4731 MAIL ADDRESS: STREET 1: 102 WOODMONT BLVD STREET 2: SUITE 610 CITY: NASHVILLE STATE: TN ZIP: 37215 FORMER COMPANY: FORMER CONFORMED NAME: Imprimis Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20120301 FORMER COMPANY: FORMER CONFORMED NAME: TRANSDEL PHARMACEUTICALS INC DATE OF NAME CHANGE: 20070912 FORMER COMPANY: FORMER CONFORMED NAME: Bywater Resources, Inc DATE OF NAME CHANGE: 20060421 4 1 ownership.xml X0306 4 2023-01-02 0 0001360214 HARROW HEALTH, INC. HROW 0001542150 BOLL ANDREW R. C/O HARROW HEALTH, INC. 102 WOODMONT BLVD, SUITE 610 NASHVILLE TN 37205 0 1 0 0 Chief Financial Officer Common Stock 2023-01-02 4 M 0 23000 A 278063 D Common Stock 2023-01-02 4 F 0 9602 14.76 D 268461 D Restricted Stock Unit 0 2023-01-02 4 M 0 23000 0 D Common Stock 23000 0 D The listed Acquired (as described in the table above) 23,000 shares of Harrow Health, Inc. ("Harrow") common stock represent restricted stock units ("RSUs") granted to Mr. Boll under the Issuer's 2017 Stock Incentive and Awards Plan on January 2, 2020. The RSUs vested in full on January 2, 2023, the third-year anniversary of the grant of the same, and settled as one share of common stock for each RSU. The listed Disposed (as described in the table above) 9,602 shares of Harrow common stock were not sold by Mr. Boll in any transaction; rather, they were shares of Harrow common stock withheld from the same aforementioned 23,000 share RSU issuance, by the Company, for payroll tax purposes only. /s/ Andrew R. Boll 2023-01-03